SCHEMBL10566832

SCHEMBL10566832

CCn1c(-c2ccc(OC)c(OC)c2)cc(=O)n(CC)c1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.46
▸ ALDH1A1 P00352 2/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ HSD17B10 Q99714 1/20 0.46
▸ LMNA P02545 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ MAPT P10636 1/20 0.41
▸ THRB P10828 1/20 0.41
▸ PDE4A P27815 6/20 0.41
▸ PDE4D Q08499 5/20 0.41
▸ PDE4B Q07343 5/20 0.41
▸ PDE4C Q08493 4/20 0.41
▸ BRD9 Q9H8M2 2/20 0.40
▸ HTR1A P08908 1/20 0.40
▸ ADORA3 P0DMS8 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ MAOB P27338 1/20 0.40
▸ ADORA2A P29274 1/20 0.40
▸ ADORA2B P29275 1/20 0.40
▸ ADORA1 P30542 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10565552 0.89 ALDH1A1 (0.44) KDM4EALDH1A1KMT2AHSD17B10SMN1; SMN2
SCHEMBL10567511 0.86 KDM4E (0.50) KDM4EALDH1A1KMT2AHSD17B10MAPT
SCHEMBL10565453 0.81 KDM4E (0.48) KDM4EALDH1A1KMT2AHSD17B10SMN1; SMN2
SCHEMBL10564675 0.79 PDE4B (0.45) KDM4EALDH1A1SMN1; SMN2MAPTTHRB
SCHEMBL10566470 0.77 PDE4B (0.44) KDM4EALDH1A1KMT2AHSD17B10LMNA
SCHEMBL10566474 0.77 PDE4B (0.44) KDM4EALDH1A1KMT2AHSD17B10LMNA
SCHEMBL11577952 0.74 ALDH1A1 (0.52) KDM4EALDH1A1KMT2AHSD17B10SMN1; SMN2
SCHEMBL10568294 0.74 TSHR (0.50) KDM4EALDH1A1MAPTTHRBPDE4A
SCHEMBL10690149 0.73 KDM4E (0.49) KDM4EALDH1A1KMT2AHSD17B10SMN1; SMN2
Hydrochloric Acid SCHEMBL11576904 0.73 ALDH1A1 (0.51) KDM4EALDH1A1KMT2AHSD17B10SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4824851-A Pyrimidones as cardiotonic, anti hypertensive, cerebrovascular vasodilator and anti-platelet agents FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-04-25 — — US disclosed
EP-0123402-B1 PYRIMIDINE DERIVATIVES, PREPARATION THEREOF AND USE THEREOF FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-09-07 — — EP disclosed
US-4746664-A Substituted-3,4-dihydro-4-(2,4,6-trimethoxyphenylimino)-2(1H)-pyrimidones useful as cardiotonic, antihypertensive, cerebrovascular vasodilator and anti-platelet agent FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-05-24 — — US disclosed
US-4612376-A Substituted-3,4-dihydro-4-(2,4,6-trimethoxyphenylimino)-2(1H)-pyrimidones useful as cardiotonic, antihypertensive, cerebrovascular vasodilator and anti-platelet agent FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1986-09-16 — — US disclosed
EP-0123402-A2 Pyrimidine derivatives, preparation thereof and use thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-10-31 — — EP disclosed
Send feedback